Metraipolis › archive › dc_b4bfaba1eab6
The impact of PSMA-PET/CT on clinical decision-making in primary staging of prostate cancer — Europe PMC PMID:42380714
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42380714
- DOI
- 10.1186/s13550-[numero omesso]-2
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T06:41:41.977Z
- SHA-256 of the archived text
f0ba7356cdee2dd95042dcb5d2176a8b1e4122643c42d8f9565e835f59318cfb- Stable URL of this page
https://metraipolis.com/documento/dc_b4bfaba1eab6
How to cite
The impact of PSMA-PET/CT on clinical decision-making in primary staging of prostate cancer — Europe PMC PMID:42380714 — Europe PMC (en), https://europepmc.org/article/MED/42380714 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b4bfaba1eab6 (Metraipolis archive dc_b4bfaba1eab6, sha256 f0ba7356cdee2dd95042dcb5d2176a8b1e4122643c42d8f9565e835f59318cfb)
BibTeX
@misc{dcb4bfaba1eab6,
title = {The impact of PSMA-PET/CT on clinical decision-making in primary staging of prostate cancer — Europe PMC PMID:42380714},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42380714},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b4bfaba1eab6; sha256 f0ba7356cdee2dd95042dcb5d2176a8b1e4122643c42d8f9565e835f59318cfb},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42380714. Agents can read the archived copy with the MCP tool read_document.